| DWS ESG BIOTECH TFC | RVI BIOTECNOLOGÍA | 44,19% | 52,41% | 36,51% | · |
| NINETY ONE GSF EMERGING MARKETS EQUITY FUND I ACC USD | RVI EMERGENTES | 44,19% | 100,20% | 68,74% | · |
| AB FCP II-EMERGING MARKETS VALUE PORTFOLIO A EUR | RVI EMERGENTES VALOR | 44,18% | 76,20% | 65,19% | 115,54% |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO IO (SNAP) JPY CAP | RVI EMERGENTES | 44,18% | 83,46% | 60,26% | · |
| NORDEA 1-EMERGING SUSTAINABLE STARS EQUITY FUND BP-EUR | RVI EMERGENTES | 44,18% | 76,78% | 24,52% | 127,57% |
| L&G HEALTHCARE BREAKTHROUGH UCITS ETF USD ACC ETF | RVI BIOTECNOLOGÍA | 44,17% | 47,65% | · | · |
| INVESCO COMMODITY ALLOCATION A CAP EUR (HEDGED) | RVI MATERIAS PRIMAS | 44,16% | 133,06% | 93,32% | 70,88% |
| GOLDMAN SACHS EMERGING MARKETS CORE EQUITY PORTFOLIO IO (SNAP) USD CAP | RVI EMERGENTES | 44,15% | 83,52% | 59,88% | · |
| MIRAE ASSET ESG ASIA SECTOR LEADER EQUITY FUND A EUR CAP | RVI ASIA EX-JAPÓN | 44,15% | 72,94% | 48,86% | · |
| BGF WORLD ENERGY X2 EUR | RVI ENERGÍA | 44,14% | 52,15% | 189,14% | · |
